Fractyl Health - GUTS Total Company Value-to-Revenue Ratio

Public company logo of Fractyl Health (GUTS)

Fractyl Health, Inc. (GUTS) adheres to standard biohazardous waste disposal and laboratory safety regulations. The EV/Sales ratio allows for the filtering of price manipulations to reveal true capitalization drivers, while the value of 0.00 characterizes this level. Scaling prospects for diabetes gene therapy promise high margins upon regulatory approval, although metabolism correction patents require complex surgical training.

GUTS Fractyl Health, Inc.: Enterprise Value-to-Revenue Ratio in the range 11/23/2025 - 11/20/2026

GUTS (Fractyl): analytical breakdowns and indicator data

Fundamental company valuation:GUTS - Fractyl Health, Inc.
Brand item of Fractyl Health Inc.

Analyzing EV/Sales is critical for constructing a defensive portfolio, as it compares the total enterprise value (market capitalization plus net debt) to sales volume, allowing for an assessment of the asset's real price without distortions from debt load. For Fractyl Health, Inc. (GUTS), which is implementing laboratory automation and metabolic testing software, the EV/Sales multiple reflects market expectations for technology scaling and signals the extent of the premium paid for future growth.

Competitor analysis for Fractyl Health, Inc.

ASND: Enterprise Value-to-Revenue Ratio|MDGL: EV/Sales Multiple|CORT - Total Company Value-to-Revenue Ratio|Enterprise Value-to-Revenue Ratio Rhythm Corp|Akero Corp (AKRO) - Total Company Value-to-Revenue Ratio|Enterprise Value-to-Revenue Ratio metsera.com (MTSR)|Company Value to Revenue moonlaketx.com MLTX|EV/Sales Multiple CRNX (Crinetics Pharmaceuticals, Inc.)|NAMS: Company Value to Revenue Ratio|SLNO - Enterprise Value-to-Revenue Ratio|Amicus Pharma (FOLD) - Company Value to Revenue|ETNB: EV/Sales Multiple|AGIO - Total Company Value-to-Revenue Ratio|Company Value to Revenue GPCR|Enterprise Value-to-Revenue Multiple MiMedx MDXG|Enterprise Value-to-Revenue Ratio Rezolute Corp (RZLT)|Company Value to Revenue Lexicon Corp LXRX|Enterprise Value-to-Revenue Ratio MBX Biosciences, Inc. MBX|EV/Sales Multiple altimmune.com ALT|AARD - Enterprise Value-to-Revenue Ratio|Sagimet - Enterprise Value-to-Revenue Coefficient|BioAge Labs Inc. (BIOA) - Enterprise Value-to-Revenue Ratio|Enterprise Value to Sales Volume BMEA (Biomea Fusion, Inc.)|QNCX (quincetx.com) - EV/Sales Multiple|EV/Sales Multiple vtvtherapeutics.com|Company Value to Revenue ATPC (Agape ATP Corp)|Total Company Value-to-Revenue Ratio Pluristem Therapeutics|Enterprise Value-to-Revenue Ratio synlogictx.com SYBX|LPCN: Company Value to Revenue Ratio|MTNB - Enterprise Value-to-Revenue Ratio|Spruce Biosciences, Inc. (SPRB) - Company Value to Revenue|GLTO: EV/Sales Multiple|Enterprise Value-to-Revenue Multiple Carmell Corp. (CTCX)|LUMO (Lumos Therapeutics) - EV/Sales Multiple|Organovo Corp (ONVO) - Total Company Value-to-Revenue Ratio|Enterprise Value-to-Revenue Ratio Radius Recycling (RDUS)